Confused? Let us clarify: These ovarian cancer screening tests are still recommended for women at high risk (i.e., any woman who has had breast cancer; who has the BRCA-1 and BRCA-2 genes; who has a relative who has had breast cancer, colorectal cancer, or ovarian cancer; or anyone who is obese. The heaviest women have a 50% increased risk of ovarian cancer.
The USPSTF is warning against screening tests for everyone else because they result in too many false positives. In the words of the USPSTF, "screening for ovarian cancer can lead to important harms, including major surgical interventions in women who do not have cancer."
The good news is many companies are working on ovarian cancer diagnostic tests that may be more reliable: blood tests that look for multiple cancer markers, not just CA-125; monoclonal antibodies that target ovarian cancer cells types; and gene- and protein-based tests.